NanoviricidesNNVC +3.82%35 Market Cap is $31.26 Mil as of Jun. 25, 2026. GuruFocus rates NNVC with a GF Score™ of 35/100. Among 1,430 Biotechnology companies, Nanoviricides ranks worse than 71.26% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Nanoviricides's share price for the quarter that ended in Mar. 2026 was $0.9121. Nanoviricides's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 21.65 Mil. Therefore, Nanoviricides's market cap for the quarter that ended in Mar. 2026 was $19.74 Mil.
Nanoviricides's quarterly market cap
declined
from Sep. 2025 ($25.11 Mil) to Dec. 2025 ($24.40 Mil) and
declined
from Dec. 2025 ($24.40 Mil) to Mar. 2026 ($19.74 Mil).
Nanoviricides's annual market cap
increased
from Jun. 2023 ($13.45 Mil) to Jun. 2024 ($22.61 Mil) and
increased
from Jun. 2024 ($22.61 Mil) to Jun. 2025 ($23.25 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Nanoviricides's Enterprise Value for Today is $28.05 Mil.
Nanoviricides (AMEX:NNVC) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Nanoviricides Market Cap Related Terms
Nanoviricides Market Cap Historical Data
* Premium members only.
The historical data trend for Nanoviricides's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Nanoviricides's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nanoviricides Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nanoviricides's Market Cap distribution charts can be found below:
* The bar in red indicates where Nanoviricides's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Nanoviricides's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nanoviricides (NNVC) has a Market Cap of $31.26 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nanoviricides and its competitors. According to the industry distribution chart, Nanoviricides ranks #1019 out of 1430 companies in the Biotechnology industry, placing it in the top 71.3%.
Is Nanoviricides' Market Cap too high?
Nanoviricides' current Market Cap is $31.26 Mil. The Biotechnology industry median Market Cap is 117.26. Nanoviricides' value of $31.26 Mil is 73.3% below this industry median. Based on the distribution chart, Nanoviricides ranks #1019 out of 1430 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Nanoviricides has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Nanoviricides' Market Cap compare to RNXT and PSTV?
According to the Biotechnology industry distribution chart, Nanoviricides ranks #1019 out of 1430 companies for Market Cap. This places Nanoviricides in the lower half of its industry. The industry median Market Cap is 117.26. Nanoviricides' value of $31.26 Mil is 73.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 117.26, based on 1,430 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nanoviricides's current Market Cap of $31.26 Mil is 73.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nanoviricides and its competitors. For the Biotechnology industry, the median Market Cap is 117.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nanoviricides's current Market Cap is $31.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanoviricides stock overvalued right now?
Nanoviricides (NNVC) has a current Market Cap of $31.26 Mil. The current Market Cap is $31.26 Mil and 73.3% below the Biotechnology industry median of 117.26. Nanoviricides' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Nanoviricides (NNVC), the current Market Cap is $31.26 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
35GF Score
Get the complete analysis for NNVC
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NNVC has been successfully added to your 
